PATTIES FOODS Total Liabilities
PATTIES FOODS total liabilities. Based on the latest financial reports, PATTIES FOODS (PH4) has total liabilities worth €741.60 Million EUR (≈ $867.01 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check PATTIES FOODS (PH4) asset resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of PATTIES FOODS (2020–2025)
Total liabilities of PATTIES FOODS from 2020 to 2025. This chart illustrates how PATTIES FOODS's total liabilities have evolved over time, based on quarterly financial data.
PATTIES FOODS Competitors by Total Liabilities
The table below lists competitors of PATTIES FOODS ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Companhia Siderúrgica Nacional
SA:CSNA3
|
Brazil | R$83.47 Billion |
|
Omnia Holdings Limited
JSE:OMN
|
South Africa | ZAC8.43 Billion |
|
Jiangsu Hongdou Industrial Co Ltd
SHG:600400
|
China | CN¥1.52 Billion |
|
HYDROGRAPH CLEAN POWER
F:M98
|
Germany | €2.34 Million |
|
Aedas Homes SL
MC:AEDAS
|
Spain | €1.23 Billion |
|
UP FINT. HLDG (SP.ADR) A
F:1M5
|
Germany | €8.01 Billion |
|
EPIC Suisse AG
SW:EPIC
|
Switzerland | CHF870.23 Million |
|
BALTIC CLASSIF.GR LS 001
F:983
|
Germany | €95.36 Million |
Liability Composition Analysis (2020–2025)
This chart breaks down PATTIES FOODS's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see PATTIES FOODS assets under control.
Liquidity & Leverage Metrics
PATTIES FOODS Total Liabilities Ratios Explained
PATTIES FOODS total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.18 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.20 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.55 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how PATTIES FOODS's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for PATTIES FOODS (2020–2025)
The table below shows the annual total liabilities of PATTIES FOODS from 2020 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €741.60 Million ≈ $867.01 Million |
-27.97% |
| 2024-12-31 | €1.03 Billion ≈ $1.20 Billion |
-14.57% |
| 2023-12-31 | €1.21 Billion ≈ $1.41 Billion |
+1.35% |
| 2022-12-31 | €1.19 Billion ≈ $1.39 Billion |
+11.71% |
| 2021-12-31 | €1.06 Billion ≈ $1.24 Billion |
+31.69% |
| 2020-12-31 | €808.29 Million ≈ $944.98 Million |
-- |
About PATTIES FOODS
CStone Pharmaceuticals, a biopharmaceutical company, researches and develops anti-cancer therapies to address the unmet medical needs of cancer patients in Mainland China and internationally. The company offers CEJEMLY (sugemalimab), a monoclonal antibody against programmed death (PD) ligand 1 for the treatment of non-small cell lung cancer (NSCLC), gastric adenocarcinoma/gastroesophageal junctio… Read more